AR033262A1 - Procedimiento para la preparacion de 2-[5-(4-fluorofenil)-3-piridilmetilaminometil]-cromano - Google Patents

Procedimiento para la preparacion de 2-[5-(4-fluorofenil)-3-piridilmetilaminometil]-cromano

Info

Publication number
AR033262A1
AR033262A1 ARP020101480A ARP020101480A AR033262A1 AR 033262 A1 AR033262 A1 AR 033262A1 AR P020101480 A ARP020101480 A AR P020101480A AR P020101480 A ARP020101480 A AR P020101480A AR 033262 A1 AR033262 A1 AR 033262A1
Authority
AR
Argentina
Prior art keywords
formula
salts
procedure
fluorophenyl
pyridylmethylaminomethyl
Prior art date
Application number
ARP020101480A
Other languages
English (en)
Inventor
Heinz Bokel
Neuenfeld Steffen Dr
Elke Simon
Udo Helm
Helmut Reubold
Ludwig Gantzert
Ralf Knierieme
Devant Ralf Dr
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of AR033262A1 publication Critical patent/AR033262A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Se describe un procedimiento para la preparacion de 2-[5-(4-fluorofenil)-3-piridilmetilaminometil]cromano de formula (1) de sus enantiomeros y de sus sales, caracterizado porque (1) se hace reaccionar el 5-(4-fluorofenil)piridin-3-carbaldehido de formula (2) directamente con 2-aminometilcromano o sus sales en condiciones reductivas para obtener el compuesto de formula (1), y (2) si se desea, se transforma el compuesto resultante de formula (1) en una de sus sales aceptables desde el punto de vista fisiologico por tratamiento con un ácido. La ventaja del procedimiento frente al procedimiento descripto en la patente estadounidense 5767132 radica en la disminucion del producto secundario debido a la supresion de la doble alquilacion. Al optar este procedimiento se obtiene un ingrediente activo que no contiene producto secundario con dos radicales de arilpiridina, lo cual facilita la purificacion del ingrediente activo. Además, frente a las aminaciones reductivas que se producen en condiciones estándar el procedimiento mencionado más arriba presenta la ventaja de necesitar de una menor cantidad de reactivos y una menor carga térmica. Esto, a su vez, implica una menor cantidad de impurezas y de reacciones secundarias. El 2-[5-(4-fluorofenil)-3-piridilmetilaminometil]cromano de formula (1) y sus sales son antagonistas selectivos del receptor para dopamina D2 y agonistas del receptor para 5-HT1A.
ARP020101480A 2001-04-26 2002-04-24 Procedimiento para la preparacion de 2-[5-(4-fluorofenil)-3-piridilmetilaminometil]-cromano AR033262A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10120619A DE10120619A1 (de) 2001-04-26 2001-04-26 2-(5-(4-Fluorphenyl)-3-pyridylmethylaminomethyl-chroman

Publications (1)

Publication Number Publication Date
AR033262A1 true AR033262A1 (es) 2003-12-10

Family

ID=7682908

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP020101480A AR033262A1 (es) 2001-04-26 2002-04-24 Procedimiento para la preparacion de 2-[5-(4-fluorofenil)-3-piridilmetilaminometil]-cromano

Country Status (24)

Country Link
US (1) US7045629B2 (es)
EP (1) EP1383763B1 (es)
JP (1) JP2004526797A (es)
KR (1) KR100839168B1 (es)
CN (1) CN100430391C (es)
AR (1) AR033262A1 (es)
AT (1) ATE306485T1 (es)
AU (1) AU2002257763B2 (es)
BR (1) BR0209179A (es)
CA (1) CA2445207C (es)
CZ (1) CZ301615B6 (es)
DE (2) DE10120619A1 (es)
DK (1) DK1383763T3 (es)
ES (1) ES2250647T3 (es)
HK (1) HK1077302A1 (es)
HU (1) HU229151B1 (es)
MX (1) MXPA03009684A (es)
MY (1) MY130616A (es)
PL (1) PL208705B1 (es)
RU (1) RU2288229C2 (es)
SI (1) SI1383763T1 (es)
SK (1) SK287477B6 (es)
WO (1) WO2002088117A2 (es)
ZA (1) ZA200309164B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8030336B2 (en) * 2002-12-13 2011-10-04 Ym Biosciences Australia Pty Ltd Nicotinamide-based kinase inhibitors
BRPI0608353A2 (pt) * 2005-02-17 2009-12-01 Wyeth Corp derivados de indol, benzotiofeno, benzofurano e indeno cicloalquilfundidos
US7365095B2 (en) * 2005-04-22 2008-04-29 Wyeth Chromane and chromene derivatives and uses thereof
ATE428416T1 (de) * 2005-06-21 2009-05-15 Merck Patent Gmbh Feste pharmazeutische zubereitung enthaltend (r)- (-)-2-ä5-(4-fluorophenyl)-3- pyridylmethylaminomethylü-chroman
JP2009534399A (ja) * 2006-04-18 2009-09-24 アボット・ラボラトリーズ バニロイド受容体サブタイプ１型（ｖｒ１）の拮抗薬およびその使用
SG187146A1 (en) * 2010-07-20 2013-02-28 Glaxo Group Ltd Process for preparing pyrano - [2,3-c]pyridine derivatives

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4135474A1 (de) * 1991-10-28 1993-04-29 Bayer Ag 2-aminomethyl-chromane
FR2701479B1 (fr) 1993-02-11 1995-05-12 Pf Medicament Nouveaux dérivés hétérocycliques de l'aminométhyl-4 pipéridine, leur préparation et leur application en thérapeutique.
ATE256130T1 (de) * 1993-08-19 2003-12-15 Janssen Pharmaceutica Nv Gefässverengende dihydrobenzopyranderivate
GB9318431D0 (en) * 1993-09-06 1993-10-20 Boots Co Plc Therapeutic agents
SI0707007T1 (en) * 1994-10-14 2002-04-30 Merck Patent Gmbh (R)-(-)-2-(5-(4-fluorophenyl)-3-pyridylmethylaminomethyl)chromane as CNS active agent
DE10005150A1 (de) 2000-02-07 2001-08-09 Merck Patent Gmbh Verfahren zur Herstellung von 5-Arylnicotinaldehyden

Also Published As

Publication number Publication date
RU2288229C2 (ru) 2006-11-27
HU229151B1 (hu) 2013-09-30
KR100839168B1 (ko) 2008-06-17
SI1383763T1 (sl) 2006-04-30
SK287477B6 (sk) 2010-11-08
RU2003132433A (ru) 2005-04-20
WO2002088117A3 (de) 2002-12-27
ATE306485T1 (de) 2005-10-15
CA2445207C (en) 2010-03-02
ZA200309164B (en) 2004-09-29
KR20040010616A (ko) 2004-01-31
AU2002257763B2 (en) 2007-03-15
CN100430391C (zh) 2008-11-05
DE50204535D1 (de) 2006-02-23
EP1383763B1 (de) 2005-10-12
HUP0303969A3 (en) 2011-02-28
WO2002088117A2 (de) 2002-11-07
CN1622944A (zh) 2005-06-01
DK1383763T3 (da) 2006-02-06
MY130616A (en) 2007-07-31
DE10120619A1 (de) 2002-10-31
US7045629B2 (en) 2006-05-16
MXPA03009684A (es) 2004-02-12
EP1383763A2 (de) 2004-01-28
CA2445207A1 (en) 2002-11-07
HUP0303969A2 (hu) 2004-04-28
CZ20033214A3 (cs) 2004-02-18
PL363281A1 (en) 2004-11-15
PL208705B1 (pl) 2011-05-31
CZ301615B6 (cs) 2010-05-05
SK14332003A3 (sk) 2004-04-06
US20040138266A1 (en) 2004-07-15
HK1077302A1 (en) 2006-02-10
JP2004526797A (ja) 2004-09-02
BR0209179A (pt) 2004-08-03
ES2250647T3 (es) 2006-04-16

Similar Documents

Publication Publication Date Title
NO20051010L (no) Triazolderivater som transformerende vekst faktor (TGF) inhibitorer
MXPA03011484A (es) Heteroarilos multiciclicos sustituidos con quinuclidinas para el tratamiento de enfermedades.
MA29619B1 (fr) Derive de 1,1 -dioxyde de 1,4-benzothiazepine, procede de preparation, medicaments comprenant ce compose, et utilisation de celui-ci comme hypolipidemiant
ZA200700765B (en) Nebivolol and its pharmaceutically acceptable salts, process for preparation and pharmaceutical compositions of nebivolol
NO20052733L (no) C-6 modifiserte indazolylpyrrolotriaziner
UY26839A1 (es) Productos de derivados de la 4 - fenil - piridina
EP2412707A3 (en) 3-[2-(3-Amino-2-oxo-2H-pyridin-1-yl)-acetylamino]-4-oxo-pentanoic acid derivatives and their use as caspase inhibitors
NO20051008L (no) Nye imidazolforbindelser som transformerende vekst faktor (TGF) inhibitorer
CY1105362T1 (el) Παραγωγα σουλφοναμιδιου, η παρασκευη τους και η εφαρμογη αυτων ως φαρμακα
NO20055714L (no) Inhibitorer av fosfatidylinositol 3-kinase
MXPA04003007A (es) Compuestos azabiciclico sustituidos condensados con heteroarilo para el tratamiento de enfermedades.
NO20052739L (no) CCR5-antagonister som medikamenter
ATE353888T1 (de) Chinazolinderivate
DOP2002000422A (es) Agentes antibacterianos.
NO20081844L (no) Terapeutiske forbindelser
PE20070760A1 (es) Formulaciones de quinolinonas para el tratamiento del cancer
HK1097474A1 (en) Carbostyril derivatives for accelerating salivation
MX2022007105A (es) Formas solidas de sal de 1,3-dihidroxi-2-(hidroximetil)propan-2-am ina de acido 2-((4-((s)-2-(5-cloropiridin-2-il)-2-metilbenzo[d][1, 3] dioxol-4-il)piperidin-1-il)metil)-1-(((s)-oxetan-2-il) metil)-1h- benzo[d]imidazol-6-carboxilico.
ECSP044999A (es) Agentes antidiabeticos
ATE523498T1 (de) Hiv-inhibierende 2-(4- cyanophenylamino)pyrimidinderivate
UA84896C2 (ru) Производные гидронопола как агонисты человеческих рецепторов orl1
NO20060718L (no) Substituerte tiofoner og deres anvendelse
AR033262A1 (es) Procedimiento para la preparacion de 2-[5-(4-fluorofenil)-3-piridilmetilaminometil]-cromano
PA8571201A1 (es) Polimorfo del acido 4-[2-[4-[1-(2-etoxietil)-1h-bencimidazol-2-il]-1-piperidinil]etil]-alfa, alfa-dimetil-bencenoacetico
GEP20074058B (en) 4-(7-halo-2-quino(xa) linyloxy-phenoxy-propionic acid derivatives as antineoplastic agents

Legal Events

Date Code Title Description
FB Suspension of granting procedure